Depsonil 25 Tablet 10

Depsonil 25 Tablet can interact with medications, including:

• Antihypertensives such as guanethidine, bethanidine, and methyldopa. This tablet can block the effects of these drugs.
• Antiepileptics such as carbamazepine, phenytoin, and phenobarbital. These medications may accelerate the metabolism and lower blood concentrations of this tablet, resulting in decreased efficacy. 
• Benzodiazepines such as nitrazepam, diazepam, alprazolam, and oxazepam. This tablet can increase the effects of these medications.
• Selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine and fluvoxamine. These medications can increase the blood concentration of this tablet.
• Anticoagulants such as warfarin. This tablet may increase the anti-coagulant effect of this medication.
• Antihistamines such as chlorpheniramine. This tablet may increase the effect of this medication.
• Antineoplastic agents such as altretamine. The concomitant use of altretamine with this tablet should be avoided due to the risk of severe hypotension.
• Muscle relaxants such as baclofen . This tablet may enhance the muscle relaxant effect of baclofen.
• Painkillers such as nefopam, codeine, tramadol, and dihydrocodeine. There is an increased risk of side effects on concomitant use of these medications.
• Antiarrhythmics, such as quinidine. These medications can inhibit the metabolism of this tablet.
• Calcium-channel blockers diltiazem and verapamil. The blood levels of this tablet may be increased by these medications.
• Beta-blockers such as propranolol and labetalol. These medications may increase the blood levels of this tablet.
• H2 blockers such as cimetidine. This medication may increase the plasma levels of this tablet.
• Catechol-O-methyl transferase (COMT) inhibitor such as entacapone. The concomitant use of these medications may enhance the central nervous system toxicity.
• Oral contraceptives such as norethindrone or hormone replacement therapy (HRT). These medications may accelerate the metabolism and lower blood concentrations of this tablet.
• Nasal decongestants such as phenylephrine. This tablet may increase the effect of phenylephrine.
• Thyroid medications such as levothyroxine. The concomitant use of thyroid medications and this tablet may aggravate the unwanted cardiac effects.

Depsonil 25 Tablet can interact with diseases, including:

• Thyroid disorders: This tablet may influence thyroid function, and caution is needed in individuals with thyroid disorders to avoid adverse effects on thyroid hormone levels.
• Urinary retention: The medication may exacerbate urinary retention, and individuals with a history of difficulty in urination or urinary retention should use this tablet cautiously.
• Severe kidney disease: In cases of severe kidney disease, the dosage of this tablet may need adjustment, as impaired kidney function can affect the elimination of the drug from the body.
• Severe liver disease: Liver function may be affected by this tablet, and individuals with severe liver disease should use the medication cautiously, as the liver plays a role in drug metabolism.
• Enlarged prostate: This tablet may worsen urinary symptoms in individuals with an enlarged prostate, and caution is advised to prevent exacerbation of these symptoms.
• Heart disease: Individuals with heart disease should use this tablet cautiously due to potential effects on heart rhythm and cardiovascular function.
• Porphyria: This tablet may trigger porphyria attacks in individuals with a history of this condition, characterised by the buildup of porphyrins in the body.
• Narrow-angle glaucoma: This medication may increase eye pressure, and caution is needed in individuals with narrow-angle glaucoma to prevent worsening of this condition.
• Schizophrenia: Individuals with schizophrenia should use this tablet cautiously, as the medication may interact with antipsychotic medications and affect mental health.
• Tumor of the adrenal gland: This tablet may influence adrenal gland function, and caution is required in individuals with adrenal tumours to prevent potential complications.

The recommended daily dose of this tablet should be taken as directed by your doctor. This tablet should be given just before bedtime for nocturnal enuresis in children. The dosage may change based on individual factors such as the severity of the condition and response to treatment. It is important to follow the prescribed dosage and not exceed it without consulting your doctor.

If you take an excessive amount of Depsonil 25 Tablet by accident, it is essential to take immediate medical attention from your doctor or nearby hospital. Symptoms of an overdose include disorientation, restlessness, blurred vision, dizziness, tiredness, difficulty concentrating, and low blood pressure.

If you forgot to take Depsonil 25 Tablet, take it as soon as you remember. If the time for the next dosage is close, it is recommended to skip the missed one now and resume your regular dosage pattern. Never increase your dosage without consulting your doctor.